News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,530 Results
Type
Article (30)
Press Release (3500)
Section
Business (1335)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (268)
News (2105)
Policy (116)
Tag
Academia (3)
Accelerated approval (1)
Allergies (2)
Alliances (44)
Alzheimer's disease (34)
Antibody-drug conjugate (ADC) (13)
Approvals (125)
Artificial intelligence (4)
ASCO (4)
Autoimmune disease (8)
Best Places to Work (297)
Breast cancer (20)
Cancer (153)
Cardiovascular disease (12)
Career advice (1)
Cell therapy (2)
Cervical cancer (2)
Clinical research (747)
Collaboration (9)
Compensation (4)
COVID-19 (4)
C-suite (1)
Data (212)
Depression (1)
Dermatology (2)
Diabetes (3)
Diagnostics (24)
Drug discovery (2)
Drug pricing (1)
Duchenne muscular dystrophy (2)
Earnings (1636)
Events (389)
FDA (187)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (7)
Gene editing (1)
Generative AI (1)
Gene therapy (4)
GLP-1 (10)
Government (9)
Guidances (29)
Healthcare (87)
Hematology (5)
IgA nephropathy (3)
Indications (3)
Infectious disease (5)
Inflammatory bowel disease (2)
IPO (162)
IRA (1)
Job creations (1)
Job search strategy (1)
Kidney cancer (2)
Layoffs (2)
Legal (1)
Lung cancer (48)
Lymphoma (21)
Manufacturing (4)
MASH (5)
Medical device (57)
Medtech (57)
Mergers & acquisitions (27)
Metabolic disorders (10)
mRNA (1)
Multiple sclerosis (10)
NASH (1)
Neurodegenerative disease (3)
Neuroscience (59)
NextGen: Class of 2026 (9)
Non-profit (4)
Obesity (1)
Opinion (1)
Ovarian cancer (6)
Pain (1)
Pancreatic cancer (2)
Parkinson's disease (4)
Patents (3)
Patient recruitment (2)
Peanut (1)
People (12)
Phase 1 (114)
Phase 2 (228)
Phase 3 (445)
Pipeline (262)
Policy (1)
Postmarket research (27)
Preclinical (13)
Prostate cancer (6)
Radiopharmaceuticals (6)
Rare diseases (16)
Regulatory (181)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Rett syndrome (2)
RSV (1)
Schizophrenia (6)
Sponsored (2)
Startups (3)
Vaccines (6)
Venture capital (1)
Weight loss (1)
Date
Today (1)
Last 7 days (8)
Last 30 days (45)
Last 365 days (424)
2026 (189)
2025 (424)
2024 (419)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (382)
Australia (15)
California (144)
Canada (34)
China (24)
Colorado (1)
Connecticut (6)
Delaware (23)
Europe (700)
Florida (15)
Georgia (2)
Illinois (19)
Indiana (25)
Japan (34)
Kansas (1)
Maryland (25)
Massachusetts (94)
Minnesota (12)
New Jersey (109)
New York (62)
North Carolina (20)
Northern California (97)
Ohio (5)
Pennsylvania (37)
South America (5)
Southern California (44)
Texas (25)
United States (627)
Utah (8)
Virginia (1)
Washington State (7)
3,530 Results for "%E2%80%9D%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kallyope’s Phase 2b Study of Elismetrep, A Novel Approach for Treating Migraine, Presented at the American Academy of Neurology Annual Meeting
April 23, 2026
·
6 min read
Press Releases
Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers
May 26, 2026
·
11 min read
Press Releases
Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations
June 11, 2026
·
15 min read
Press Releases
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) demonstrates prolonged clinical benefit as a first-line treatment for atypical EGFR-mutated non-small cell lung cancer
June 1, 2026
·
32 min read
Press Releases
Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS
April 22, 2026
·
10 min read
Press Releases
Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer
June 1, 2026
·
19 min read
Press Releases
Fortrea Reports First Quarter 2026 Results
May 5, 2026
·
16 min read
Press Releases
Bial Announces Completion of Phase 2b ACTIVATE Study with BIA 28-6156 in GBA1-Associated Parkinson’s
May 26, 2026
·
5 min read
Press Releases
Merck KGaA, Darmstadt, Germany, Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer
May 21, 2026
·
7 min read
Press Releases
Lilly to showcase oncology portfolio across tumor types and treatment modalities at the 2026 American Society of Clinical Oncology Annual Meeting
May 22, 2026
·
49 min read
1 of 353
Next
